- Accesswire•9 days ago
NEW YORK, NY / ACCESSWIRE / January 11, 2017 / The Nasdaq Composite Index has gained 2.76 percent over the first five trading session of the year, its best five day period to begin the year in a decade ...
- GlobeNewswire•16 days ago
CHAPEL HILL, N.C., Jan. 04, 2017-- Cempra, Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, ...
- Accesswire•17 days agoINVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Cempra, Inc. and Reminds Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / January 3, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Cempra, Inc. ("Cempra" or the "Company") (NASDAQ: ...
CEMP : Summary for Cempra, Inc. - Yahoo Finance
Cempra, Inc. (CEMP)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||3.15 x 32600|
|Ask||3.20 x 13700|
|Day's Range||3.05 - 3.20|
|52 Week Range||2.55 - 26.95|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.41|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|